Limitations of synthetic biomaterials for abdominal wall repair have led investigators to seek naturally derived matrices, such as human acellular dermis, because of their excellent biocompatibility and their ability to naturally interface with host tissues with minimal tissue response. In this study, we investigated two different biomaterials derived from human dermis (FlexHD acellular dermis and FlexHD acellular dermis-thick) in a rabbit abdominal hernia repair model. One quarter of the abdominal wall was replaced with each biomaterial, and the animals were followed for up to 24 weeks. Rabbit hernias repaired with AlloDerm(R), a commercially available acellular dermal matrix, and sham operated animals served as controls. Retrieved samples of these implants were assessed grossly and histologically. Collagen production measurements and tension studies were performed. FlexHD acellular dermis, FlexHD acellular dermis-thick, and AlloDerm(R) maintained their strength in the rabbit hernia repair model with no incidence of hernia formation or bowel adhesion. The exact size measurements at 24 weeks were 217.0 +/-20.9% for FlexHD acellular dermis, 200.8 +/-23.5% for FlexHD acellular dermis-thick, and 209.7 +/-32.9% for AlloDerm(R). Macroscopic and microscopic evaluation showed excellent integration and tissue formation. All biomaterials studied harbored cells that produced new collagen fibers, and a six-fold increase in these fibers was observed at 24 weeks. This study shows that acellular biomaterials derived from human dermis are suitable for abdominal hernia repair. Acellular Dermis -THICK, and 209.7 ± 32.9% for AlloDerm®. Macroscopic and microscopic evaluation showed excellent integration and tissue formation. All biomaterials studied harbored cells that produced new collagen fibers, and a 6-fold increase in these fibers was observed at 24 weeks. This study shows that acellular biomaterials derived from human dermis are suitable for abdominal hernia repair.
Introduction
Both synthetic implants and naturally derived tissue matrices have been used as biomaterials for abdominal wall repair [1] [2] [3] [4] [5] . Although synthetic materials, such as polypropylene mesh, are able to provide the required tensile strength to support abdominal viscera, this material is associated with untoward effects, including fibrotic encapsulation, infection, erosion and mesh extrusion, and these issues remain a problem 4, [6] [7] [8] [9] [10] [11] [12] [13] . Increasingly, naturally derived processed tissue matrices, such as human acellular dermis, human dura and bovine pericardium, have been used because of their biocompatible characteristics [14] [15] [16] . Biocompatibility is one of the most critical factors when considering a material for clinical use 17 . For this reason, investigators have sought a tissue matrix that could naturally interface with host tissues with minimal host response [18] [19] [20] [21] .
An ideal biomaterial for abdominal wall repair should be biocompatible and nonimmunogenic. It should also be able to promote the formation of new tissue through cellular ingrowth and be able to withstand the tensile forces created by the abdominal viscera and maintain structural integrity 2, 3, 15 . Because acellular human dermis appears to possess these characteristics, it has been evaluated as a material for abdominal wall repair. FlexHD Acellular Dermis and FlexHD Acellular Dermis-THICK are matrices that are naturally derived, biodegradable, and primarily composed of collagen from human skin. Both materials were developed as biomaterials for surgical fascial replacement and have good tissue handling characteristics 22 . While there is a commercially available Page 4 product (AlloDerm®) that originates from the same tissue source, the processing techniques distinguish these materials from each other.
AlloDerm® is an acellular dermal matrix prepared from human skin. Skin is procured from cadaveric donors and aseptically processed to remove the epidermis. A hyperosmolar sodium chloride solution is used to separate the dermal and epidermal layers. Sodium deoxycholate is then utilized for cell removal. The acellular dermis is cryoprotected prior to freeze drying and packaging, leaving an intact matrix with basement membrane components 23 . AlloDerm has been reported to be a suitable biomaterial in several clinical applications, including abdominal wall repair [23] [24] [25] [26] [27] and breast reconstruction 28 .
The present study was designed to assess the biocompatibility and feasibility of using this type of acellular dermis matrix as a fascial tissue substitute for abdominal wall repair. The objectives of this study were to test the ability of acellular dermal matrix to support tissue formation in the abdomen and to determine the utility of acellular dermis as a biocompatible fascial tissue substitute for abdominal wall repair. We examined whether acellular dermis provides adequate support and strength for in vivo abdominal applications.
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MATERIAL AND METHODS

Human Dermis Preparation
Flex HD Acellular Dermis (group I) and FlexHD Acellular Dermis-THICK (group II) are derived from human allograft skin that is processed using proprietary procedures developed by MTF (Musculoskeletal Transplant Foundation, Edison, NJ). Prior to tissue harvest, the donor's medical and social histories are screened for any abnormal medical pathology, disease processes and other pertinent information that would cause the donor to be unsuitable for human transplant. The screening process is completed by the MTF's highly trained National On-Call Coordinators using the strict standards developed by the MTF Medical Board of Trustees. Donors are screened for a series of diseases including, but not limited to, HIV, HTLV I and II, hepatitis B and C and syphilis.
MTF donor screening procedures and serologic and microbiologic testing policies meet current established industry standards. At MTF, skin is processed aseptically in a controlled clean room environment that meets current AATB standards 29 .
Donor skin grafts are decellularized to reduce the occurrence of adverse immune responses in graft recipients 30, 31 . This decellularization procedure involves a series of soaks and water rinses performed under gentle agitation. The tissue is first soaked overnight at ambient temperature in a hypertonic, 1M sodium chloride solution, followed by water rinses. The skin is then soaked in 0.1% Triton X-100 non-ionic detergent to remove cellular fragments. A thorough water rinse is then performed to remove detergent residuals from the tissue. A residual detergent test using Gas
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Chromatography (HPLC) is performed to ensure detergent levels are sufficiently low.
The measured concentration of sodium chloride and Triton X-100 must be lower then 10 PPM. The acellular dermis is then subjected to a disinfection process in a solution containing alcohol, peracetic acid [less than 1% (v/v), prepared from 35-40% stock solution], and propylene glycol. The matrix is gently agitated under vacuum and then rinsed with sterile water. Residual analysis of reagents used in the preparation of acellular dermis are then performed using GC-MS and HPLC to confirm that residuals are below established safety limits (0.001%). Matrix integrity is assessed throughout processing using light and electron microscopy to verify normal collagen bundle patterns and macroscopic collagen matrix structure, as well as to confirm the removal of cellular material. Following disinfection, the dermal matrices are immersed in 70%
ethanol solution and packaged in a sterile impermeable pouch. The biomaterials are tested for sterility in accordance with procedures in the current United States Pharmacopeia (USP) 32 .
The MTF dermal disinfection process has been validated to demonstrate a six log reduction in a panel of microorganisms most commonly found in the body or on the skin. 
Biomaterial characterization and ultra structure
Prior to in vivo implantation all 3 biomaterials were analyzed using scanning electron microscopy (SEM). For ultrastructural analysis, the biomaterials were placed in PBS and frozen at -80 O C. After lyophilisation under vacuum, the samples were sputtered using a gold platinum target and analyzed using a scanning electron microscope at various magnifications. Morphometric analysis was performed to evaluate the pore size by measuring 15 random pores. In oval shaped pores the smaller diameter was recorded. Further, pepsin-soluble collagen was measured by collagen assay and biomechanical testing was performed (see below).
Animal Model
The animal study was performed in accordance with the Animal Care and Use Dermis-THICK grafts. Two control groups were used. In Group III, the commercial product AlloDerm® was used, and in group IV a sham operation was performed. Four animals from each group were sacrificed at 6, 12 and 24 weeks after implantation.
Surgery Preparation and Anesthesia
The animals were sedated with an intramuscular injection of 35 mg/kg ketamine and 5mg/kg xylazine. The animals were intubated and anesthesia was maintained with 2% to 3% isoflurane. One milliliter of blood was drawn for analysis (hematogram) prior to graft implantation and at the time of sacrifice. All animals received a single dose of antibiotics (Enrofloxacin 2.5 mg/kg). The surgical site was shaved and prepped in a sterile manner. The animals were placed in the supine position.
Abdominal Surgery
A midline abdominal incision was made and the subcutaneous tissue layer on the left side of the abdomen was bluntly dissected. A 4 x 6 cm defect was created by excising a full thickness portion of the abdominal wall. Care was taken not to harm internal organs.
All biomaterials were soaked for 10 minutes in normal saline followed by a soak in 0.1% gentamicin solution for 10 minutes, after which the material was trimmed to fit the defect.The biomaterial was sutured to the abdominal musculature with 3-0 Prolene (non-absorbable) running sutures and the exact size was measured and recorded.
The sham operation included a midline abdominal incision with dissection of the same subcutaneous layers, but without removal of tissue. The abdomen was then closed with 3-0 Prolene sutures in a running fashion. The wound closure was performed in a running fashion with subcutaneous 3-0 Vicryl (absorbable) and 3-0 PDS (absorbable)
sutures for the skin.
Postoperative Care
At the end of the procedure, the animals were extubated and transferred to the postoperative care unit. All animals were closely observed for at least 4 hours until fully
awake. An intramuscular dose of buprenorphine (0.02 mg/kg) was given every 12 hours for the first 72 hours post-operatively, and as needed thereafter. Fecal and urinary output were monitored and recorded.
Implant retrieval and gross examination
Immediately after euthanasia, the implant site was inspected. Parameters assessed via gross examination included hernia formation, size and integration of the biomaterial into surrounding connective tissue. The sites were also inspected for evidence of fibrosis, infection and inflammatory responses. The dimensions of each biomaterial segment were measured and the average change was expressed as a percent of the original size. The size of the biomaterials prior to surgery was defined as 100%.
Measurements of abdominal bulging and hernia formation were made after euthanasia, with the abdomen still closed, by laying the animal in supine position and gently pressing on the abdominal wall surrounding the implant. Any extrusion of the abdomen with significant ballooning of greater than 3cm was recorded as bulging. Hernia was defined as macroscopic rupture of the biomaterial at the time of retrieval.
The implanted biomaterials were harvested through a midline incision. To reduce the risk of perforation of the implanted grafts, the abdomen was opened with an incision through the rectus muscle on the opposite side. Adhesion to the biomaterial was scored for extent (%) using the Modified Diamond Scale (0 = 0%, 1 <or= 25%, 2 = 25-50%, 3 > 50%) 33 . After assessing the levels of adherence, the biomaterial was freed from the 
Histology
The retrieved tissue specimens were fixed in 10% neutral formalin for 12 hours. All Briefly, 1ml of Sircol dye reagent was added and the samples were mixed for 30 minutes. After centrifugation, the pellet was suspended in 1 ml of alkali reagent included in the kit and read at 540 nm with a spectrophotometer. Standards were produced using the collagen supplied in the kit. The results were expressed as µg collagen per mg of biomaterial (wet weight).
Statistical Analysis
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All numerical data are expressed as averages and the corresponding standard error of the mean (SEM). For statistical analysis we used SPSS v11 (SPSS Inc). Differences between the groups and different time points were analyzed by one-way analysis of variance (ANOVA) followed by a Bonferroni test for multiple comparisons. A p value of less than 0.05 was considered significant.
Results
Characterization and ultra structure of the biomaterials
The ultrastructural analysis with SEM demonstrated a distinct difference between the biomaterials (Figure 1 
In Vivo Animal Studies
There were no surgical complications or postoperative problems. One animal expired during intubation and was replaced immediately with a new rabbit, since this death was unrelated to the study.
Gross examination
The implants and the surrounding tissues were inspected grossly after euthanasia (Figure 2 ). There were no hernias observed at the time of retrieval in any of the groups.
However, bulging of the biomaterial without tearing was observed in all groups but
sham. The FlexHD Acellular Dermis group contained 6/16 animals with bulging (2 at 6
weeks, 2 at 12 weeks and 2 at 24 weeks), the FlexHD Acellular Dermis-THICK group Further, none of the animals developed bowel adhesions to the biomaterial.
Occasionally, a small adhesion to the suture material (PDS 4-0) was seen and bluntly dissected.
Gross examination of the retrieved tissues 6 weeks after implantation was similar for all weeks.
Biomechanical Studies
The biomechanical characteristics of the investigated biomaterials were measured at 6, 12 and 24 weeks and compared to native abdominal fascia (Figure 7 ). FlexHD Acellular
Dermis and FlexHD Acellular Dermis-THICK grafts demonstrated a decrease in maximal tensile stress (MPa) from 6 to 12 weeks followed by a significant increase in strength from 12 to 24 weeks. At that time, values similar to native fascia were observed. AlloDerm ®, on the contrary, was stronger at the start of the experiment but gradually showed a sustained loss of maximal tensile strength over time.
The maximal strain at rupture showed values that are comparable to native connective tissue for all biomaterials. The strain of FlexHD Acellular Dermis decreased from 6 to 12 weeks and regained normal values at 24 weeks. Both the FlexHD Acellular Dermis-THICK graft and AlloDerm® began with a higher strain than normal tissue at 6 weeks, which decreased in a linear fashion over time. However, both materials remained within an acceptable range of strain values during the study period.
The Young's modulus (E), a measure of the stiffness of a given material, was used to evaluate the elastic modulus of the biomaterials at 6, 12 and 24 weeks. All sampled tissues were within the range of native soft tissue. Both FlexHD Acellular Dermis grafts showed a loss of modulus from 6 to 12 weeks, but the values increased to normal values from 12 to 24 weeks. AlloDerm ® showed a loss in modulus over time, but still remained close to native controls.
Collagen Assay
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Quantification of newly synthesized collagen was performed using a pepsin-soluble collagen assay. This assay is able to quantify the cumulative synthesis of new collagen within the biomaterial 37,38 . All investigated biomaterials harbored cells that produced new collagen. A 6-fold increase was observed at 24 weeks (Figure 4 ). In the FlexHD Acellular Dermis group, production of collagen remained low until 12 weeks. However, at 24 weeks, production of collagen by ingrown cells was similar to the other groups.
The FlexHD Acellular Dermis-THICK showed a 2-3 fold increase in the newly formed collagen at 6 and 12 weeks, while the AlloDerm® showed a 3 fold increase at 6 and 12
weeks. At 24 weeks, all biomaterials showed similar amounts of newly produced collagen. There were no statistical significant differences between the groups.
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Discussion
The current standard for abdominal hernia repair is the use of a propylene mesh.
However, this non-absorbable biomaterial is known to induce the formation of a fibrotic capsule through overproduction of collagen by infiltrating fibroblasts. Although this response can successfully repair a hernia, many patients report discomfort due to its In this study we have applied a large piece of biomaterial, which may raise concerns that such a large amount of matrix may lead to untoward systemic effects 55, 56 . We have assessed the systemic response by evaluating the complete blood counts (CBC) and differentials. None of the animals showed significant changes due to the implantation of the biomaterial. Therefore, a systemic effect of acellular biomaterials derived from human dermis can be ruled out. 
Summary
